Proud of Michael Morris, a tireless champion of radiopharmaceutical research in #ProstateCancer for >20 years, who now presents evidence of survival benefit from lutetium-177-PSMA-617 in the #ASCO21 plenary @sloan_kettering meetinglibrary.asco.org/record/196661/…

Just kicked this years workshop off and excited to hear Vishal Bhatnagar, MD and Erica Horodniceanu lead some interesting sessions on physical function! How can we analyze and describe physical function for patients receiving an anti-cancer treatment? #OCEOutcomes21

Dr. Deborah Watkins Bruner was the first nurse to lead a national clinical trials network, and has focused her research on symptom management and quality of life in cancer patients, breaking new ground in patient-reported outcomes. buff.ly/3yCGvTR NRG Oncology #NCORP

Nice to collaborate w/Gita Mody on this impt paper! ePRO monitoring during lung cancer tx not only feasible but identified severe sxs lungcancerjournal.info/article/S0169-… Angela M. Stover, PhD Angie Smith Ethan Basch Arlene Chung, MD, MHA, MMCi, FAMIA Antonia V. Bennett, PhD Amylou Dueck, PhD Deborah Schrag Bellinda King-Kallimanis

Looking forward for the inaugural #ASCOPlenarySeries from Ethan Basch UNC Lineberger -Digital symptoms monitoring in the oncology community: a randomized trial! ASCO Robin Zon, MD, FACP, FASCO Julie Gralow Clifford Hudis Melissa L. Johnson George W Sledge MD

News from #ASCOPlenarySeries: Digital Symptom Monitoring With PROs in Community Practices Improves Patient QoL via Targeted Oncology @Sara_Karlo7 fal.cn/3jWkz Ethan Basch #medtech #digitalhealth #ePROs

Adolescent and young adult patients w/ #cancer are well-represented in National Cancer Institute #ClinicalTrials and are more racially/ethnically diverse than older patients acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… SWOG Cancer Research Network Fred Hutchinson Cancer Center DrJoeUnger Dawn Hershman

BREAKING🎄 The 6th preprint from G2P-Japan - #Omicron is less infectious and pathogenic than #Delta and even an early pandemic SARS-CoV-2 in infected hamster model. 1/5

How come? We have recently reported that Delta spike is efficiently cleaved into two subunits, and therefore, Delta is highly fusogenic and highly pathogenic nature . 2/5 nature.com/articles/s4158…

In sharp contrast, Omicron is less fusogenic (left panel) and its spike is faintly cleaved (right panel). Our data suggest that the efficacy of spike protein cleavage, fusogenicity and pathogenicity are well correlated each other. 3/5

Moreover, our statistical analysis shows that Omicron is >3-5-fold more transmissible than Delta. 4/5

Our pre-preprint has been uploaded (free available from the URL below). It will be come out as a preprint (and hopefully a peer-reviewed paper) pretty soon. And yes, we are G2P-Japan🇯🇵 Happy Xmas🎄 5/5 drive.google.com/file/d/1rhCazF…

New #COVID19 🦠 #openaccess resource in Annals of Oncology: COVID-19 Vaccination 💉 and Breakthrough Infections in Patients with Cancer ➡️ annalsofoncology.org/article/S0923-… COVID-19 and Cancer Consortium (CCC19) Registry Toni Choueiri, MD

Excited to present at #ASCO22, the PRO-TECT multicenter randomized trial of a PRO digital tool for symptom monitoring in US oncology practices, with simultaneous publication in JAMA JAMA, in the ASCO Plenary Series update session, 6/5/22 5:30pm EDT. Alliance for Clinical Trials in Oncology The Patient-Centered Outcomes Research Institute

#ASCO22 TOMORROW: Join presenters from the #ASCOPlenarySeries for ⚡ rapid abstract updates on their research, followed by a panel q&a moderated by George W Sledge MD & Kimmie Ng, MD, MPH  📅 6/5, 4:30 – 6:00 PM CT 📌 Arie Crown Theater & Online Ethan Basch Heinrich GIST Lab Professor Georgina Long AO

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic #Cancer. jamanetwork.com/journals/jama/… ASCO JAMA Ethan Basch Amylou Dueck, PhD #PallOnc #PROs #DigitalHealth #ASCO22

Great to see this impt work out in JAMA & honored to contribute on behalf of ASCO. Congrats to Ethan Basch & all co-authors 👉🏻 Electronic Symptom Monitoring With Patient-Reported Surveys and Outcomes Among Patients With Metastatic Cancer ja.ma/3zo2cK3 #PRO #HRQOL

New models of working for #clinical trials? Patient-informed investigator reporting of adverse events Ethan Basch Amylou Dueck, PhD #OCEoutcomes22 FDA Oncology - love this approach! @NIHRBhamBRC

On this US Labor Day, I feel gratitude for the many dedicated UNC Health and UNC Lineberger staff supporting patients with cancer, particularly after 2+ tough years with staffing shortages and Covid absences. Thank you.

Dr Joannie Ivory on Black patient participation in trials in breast cancer. Critical topic. Awesome young HSR researcher! ⁦Outcomes@Lineberger⁩